"Clinical Trials as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.
Descriptor ID |
D002986
|
MeSH Number(s) |
E05.318.760.250.500 N05.715.360.775.088.500 N06.850.520.450.250.250
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Clinical Trials as Topic".
Below are MeSH descriptors whose meaning is more specific than "Clinical Trials as Topic".
This graph shows the total number of publications written about "Clinical Trials as Topic" by people in this website by year, and whether "Clinical Trials as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 34 | 35 |
1995 | 5 | 20 | 25 |
1996 | 1 | 20 | 21 |
1997 | 0 | 29 | 29 |
1998 | 3 | 30 | 33 |
1999 | 5 | 28 | 33 |
2000 | 7 | 41 | 48 |
2001 | 4 | 63 | 67 |
2002 | 11 | 75 | 86 |
2003 | 8 | 85 | 93 |
2004 | 5 | 77 | 82 |
2005 | 12 | 68 | 80 |
2006 | 23 | 91 | 114 |
2007 | 19 | 90 | 109 |
2008 | 18 | 99 | 117 |
2009 | 24 | 103 | 127 |
2010 | 23 | 107 | 130 |
2011 | 30 | 103 | 133 |
2012 | 20 | 77 | 97 |
2013 | 20 | 68 | 88 |
2014 | 28 | 72 | 100 |
2015 | 24 | 71 | 95 |
2016 | 30 | 92 | 122 |
2017 | 22 | 80 | 102 |
2018 | 29 | 63 | 92 |
2019 | 31 | 58 | 89 |
2020 | 30 | 73 | 103 |
2021 | 20 | 54 | 74 |
2022 | 6 | 26 | 32 |
2023 | 5 | 25 | 30 |
2024 | 21 | 24 | 45 |
To return to the timeline,
click here.
Below are the most recent publications written about "Clinical Trials as Topic" by people in Profiles.
-
Combining Biology-based and MRI Data-driven Modeling to Predict Response to Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer. Radiol Artif Intell. 2025 Jan; 7(1):e240124.
-
Targeted radionuclide therapy for gliomas: Emerging clinical trial landscape. Neuro Oncol. 2024 Dec 09; 26(Supplement_9):S208-S214.
-
Next-generation combination approaches for immune checkpoint therapy. Nat Immunol. 2024 Dec; 25(12):2186-2199.
-
The future of hypertension pharmacotherapy: Ongoing and future clinical trials for hypertension. Curr Probl Cardiol. 2025 Jan; 50(1):102922.
-
Optimizing early phase clinical trial washout periods: a report from the Therapeutic Advances in Childhood Leukemia and Lymphoma consortium. J Natl Cancer Inst. 2024 Nov 01; 116(11):1721-1729.
-
Challenges and opportunities for early phase clinical trials of novel drug-radiotherapy combinations: recommendations from NRG Oncology, the American Society for Radiation Oncology (ASTRO), the American College of Radiology (ACR), the Sarah Cannon Research Institute, and the American College of Radiation Oncology (ACRO). Lancet Oncol. 2024 Oct; 25(10):e489-e500.
-
Radiation target nomenclature for lymphoma trials: consensus recommendations from the National Clinical Trials Network groups. Lancet Haematol. 2024 Dec; 11(12):e951-e958.
-
Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum. Clin Infect Dis. 2024 Sep 26; 79(3):787-794.
-
Patient and family views on research priorities and design of clinical trials and research studies in pediatric multiple sclerosis. Mult Scler. 2024 Oct; 30(11-12):1525-1543.
-
Updates for newly diagnosed and recurrent glioblastoma: a review of recent clinical trials. Curr Opin Neurol. 2024 Dec 01; 37(6):666-671.